Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Novartis pays Antares $105M to illuminate undruggable cancer targets

Novartis pays Antares $105M to illuminate undruggable cancer targets

  • June 24, 2026

Novartis is paying Antares Therapeutics $105 million upfront in a deal worth up to $1.9 billion to generate small molecules against historically undruggable oncology targets.

Leave A Comment

Fields (*) Mark are Required